Erythropoietin (EPO) Drugs Market Analysis by Drug Class (Biosimilars, Biologics), by Product (Epoetin-beta, Epoetin-alfa, Darbepoetin-alfa), by Application (Haematology, Neurology, Cancer, Renal), and by Region - Forecast to 2029

Request Sample Page

The global erythropoietin (EPO) drugs market size is estimated to be USD xx billion in 2021 and is expected to witness a CAGR of xx% during the forecast period. Rising cases of chronic illness coupled with R&D investment by biopharmaceutical and biotechnology companies for the development of novel drugs is a key driver for the growth of the global erythropoietin (EPO) drugs market. Additionally, the increase in research & development activities, government initiatives for combating adverse drug reactions, outbreak of COVID-19 pandemic, and growing demand for biologics for the treatment of chronic diseases are some of the other drivers propelling the market growth. Nevertheless, the expensive drug cost in developing and under-developed nations are expected to restrain the global market growth.

Global Erythropoietin (EPO) Drugs Market Size (USD Billion), 2021-2029

Source: Erevna Healthcare

By Drug-Class

Based on drug class, the market is segmented into biosimilars and biologics. In 2021, the biologics segment accounted for the largest revenue share. This is attributed to the escalating disease population, high patent coverage, and larger adoption rate of biologics, worldwide. Biosimilars EPO drugs segment is projected to grow at a profitable CAGR during the forecast period. This is attributed to rising patent expiration of blockbuster drugs coupled with cost-effective, easy and quicker development of biosimilar drugs for the treatment of chronic diseases.

By Product

Based on product, the market is categorized into epoetin-beta, epoetin-alfa, darbepoetin-alfa, and others. In 2021, the epoetin-alfa segment accounted for the dominant revenue share due to large acceptance among medical practitioners worldwide. Darbepoetin-alfa segment is anticipated to grow at a profitable CAGR during the forecast period, due to the affordability, higher half-life, and improved efficiency.

By Application

Based on application, the market is categorized into hematology, neurology, cancer, and renal diseases. The renal disease segment accounted for the highest revenue in 2021 and is projected to maintain its dominance over the forecast period. The rising prevalence of anaemic patients is a key factor that drives the segment growth. The cancer segment is anticipated to grow at the fastest CAGR during the forecast period owing to rising prevalence of cancer patients worldwide.

Regional Insights

In 2021, North America accounted for the highest revenue share in the global market and is expected to maintain its dominance during the forecast period. This is attributed to the presence of leading biopharmaceutical companies, advanced healthcare infrastructure, and high investments in R&D in this region. Asia Pacific market is projected to exhibit the fastest CAGR over the forecast period owing to the rising incidences of cancer patients, escalating demand for biological drugs, and growing focus of CROs & biopharmaceutical companies in this region.

Competitor Insights

Some of the key players in the erythropoietin (EPO) drugs market are Dr. Reddy’s Laboratories (India); Sun Pharmaceutical Industries Limited (India); Shandong Kexing Bioproducts Co.,Ltd. (China); Biocon Limited (India); LG Corporation (South Korea); F. Hoffmann-La Roche AG (Switzerland); Amgen Inc. (U.S.); Teva Pharmaceutical Industries Ltd. (Israel); Celltrion (South Korea) and Johnson & Johnson (U.S.). The leading players operating in the erythropoietin (EPO) drugs industry are adopting various strategies including R&D investments, adaption of advanced techniques, mergers & acquisitions, and regional expansions to capture a maximum revenue share.

This exhaustive research report focuses on market size and forecast at global, segmental, regional and country level along with key market trends and dynamics from 2021 to 2029. The erythropoietin (EPO) drugs market report is categorized into the following segments and subsegments:

Erythropoietin (EPO) Drugs Market, By Drug Class (Revenue, USD Billion, 2021 – 2029)

  • Biosimilars
  • Biologics

Erythropoietin (EPO) Drugs Market, By Product (Revenue, USD Billion, 2021 – 2029)

  • Epoetin-beta
  • Epoetin-alfa
  • Darbepoetin-alfa
  • Others

Erythropoietin (EPO) Drugs Market, By Application (Revenue, USD Billion, 2021 – 2029)

  • Haematology
  • Neurology
  • Cancer
  • Renal Diseases

Erythropoietin (EPO) Drugs Market, By Region (Revenue, USD Billion, 2021 – 2029)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of LATAM
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Rest of MEA

Scope of Erythropoietin (EPO) Drugs Market Report:

Key Parameters Details
Base Year
  • 2021
Forecast Period
  • 2022-2029
Study Coverage
  • Global and regional market size and revenue forecast
  • Segment market size and revenue forecast at global, regional, and country level
  • Competitive landscape (company share analysis, company profiles, recent development, competitive map analysis)
  • Conclusion and recommendations
Qualitative Analysis
  • Market drivers
  • Market restraints
  • Market opportunities
  • Recent market trends
  • Market challenges
  • Porter’s Five Forces analysis
  • PEST analysis
  • Value-chain analysis
  • COVID-19 impact analysis
Regional Market Scope
  • North America (U.S. and Canada)
  • Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
  • Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC)
  • Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
  • MEA (South Africa, GCC, Rest of MEA)
Company Profiles
  • Exhaustive profiles of top 15 players
  • 50+ other major players listing
15% Free Customization Available
  • You can customize the study scope to meet your exact requirement. Click here for more details

Table of Contents: Erythropoietin (EPO) Drugs Market 2021-2029

  1. Research Methodology
    1. Study Objectives
    2. Study Scope
    3. Research Assumptions
    4. Research Framework
      1. Research Models
        1. Bottom-up Approach
        2. Top-down Approach
        3. Data Triangulation
      2. Data Procurement
        1. Internal Database
        2. Secondary Research
        3. Purchased Database
        4. Primary Research
      3. Data Analysis
        1. Data Validation
        2. Market Size Estimation
        3. Market Forecast Model
      4. Quality Assessment
  1. Introduction: Erythropoietin (EPO) Drugs
  2. Executive Summary
    1. Global Market Scenario
    2. Segment Market Scenario
    3. Geographic Market Scenario
    4. COVID-19 Impact
    5. Competitive Landscape
  3. Market Dynamics
    1. Market Drivers
      1. Driver 1
      2. Driver 2
      3. Driver 3
      4. Driver 4
      5. Driver 5
    2. Market Restraint
      1. Restraint 1
      2. Restraint 2
      3. Restraint 3
      4. Restraint 4
    3. Market Opportunities
      1. Opportunity 1
      2. Opportunity 2
      3. Opportunity 3
      4. Opportunity 4
    4. Market Trends
      1. Trend 1
      2. Trend 2
      3. Trend 3
      4. Trend 4
    5. Market Challenges
      1. Challenge 1
      2. Challenge 2
      3. Challenge 3
      4. Challenge 4
  1. Market Environment Analysis
    1. Porter’s 5 Forces Analysis
    2. PESTEL Analysis
    3. Value Chain Analysis
    4. SWOT Analysis
    5. Benchmark
  2. COVID-19 Impact Analysis: Erythropoietin (EPO) Drugs Market
    1. COVID-19: Overview
    2. COVID-19 Impact on the Global Market
    3. COVID-19 Impact on the Regional Markets
  3. Market Analysis by Drug Class
    1. Biosimilars
      1. Biosimilars Market Forecast, 2021-2029 (USD Million)
    2. Biologics
      1. Biologics Market Forecast, 2021-2029 (USD Million)
  1. Market Analysis by Product
    1. Epoetin-beta
      1. Epoetin-beta Market Forecast, 2021-2029 (USD Million)
    2. Epoetin-alfa
      1. Epoetin-alfa Market Forecast, 2021-2029 (USD Million)
    3. Darbepoetin-alfa
      1. Darbepoetin-alfa Market Forecast, 2021-2029 (USD Million)
    4. Others
      1. Others Market Forecast, 2021-2029 (USD Million)
  1. Market Analysis by Application
    1. Haematology
      1. Haematology Market Forecast, 2021-2029 (USD Million)
    2. Neurology
      1. Neurology Market Forecast, 2021-2029 (USD Million)
    3. Cancer
      1. Cancer Market Forecast, 2021-2029 (USD Million)
    4. Renal Diseases
      1. Renal Diseases Market Forecast, 2021-2029 (USD Million)
  1. Regional Market Analysis
    1. Regional Market Trends
    2. Regional Market: Comparative Analysis
  2. North America Erythropoietin (EPO) Drugs Market
    1. North America Erythropoietin (EPO) Drugs Market
      1. North America Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Drug Class, 2021-2029 (USD Million)
        2. Market Size and Forecast by Product, 2021-2029 (USD Million)
        3. Market Size and Forecast by Application, 2021-2029 (USD Million)
      2. S. Erythropoietin (EPO) Drugs Market
        1. S. Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Drug Class, 2021-2029 (USD Million)
          2. Market Size and Forecast by Product, 2021-2029 (USD Million)
          3. Market Size and Forecast by Application, 2021-2029 (USD Million)
        2. Canada Erythropoietin (EPO) Drugs Market
          1. Canada Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Drug Class, 2021-2029 (USD Million)
            2. Market Size and Forecast by Product, 2021-2029 (USD Million)
            3. Market Size and Forecast by Application, 2021-2029 (USD Million)
  1. Europe Erythropoietin (EPO) Drugs Market
    1. Europe Erythropoietin (EPO) Drugs Market
      1. Europe Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Drug Class, 2021-2029 (USD Million)
        2. Market Size and Forecast by Product, 2021-2029 (USD Million)
        3. Market Size and Forecast by Application, 2021-2029 (USD Million)
      2. Germany Erythropoietin (EPO) Drugs Market
        1. Germany Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Drug Class, 2021-2029 (USD Million)
          2. Market Size and Forecast by Product, 2021-2029 (USD Million)
          3. Market Size and Forecast by Application, 2021-2029 (USD Million)
        2. UK Erythropoietin (EPO) Drugs Market
          1. UK Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Drug Class, 2021-2029 (USD Million)
            2. Market Size and Forecast by Product, 2021-2029 (USD Million)
            3. Market Size and Forecast by Application, 2021-2029 (USD Million)
          2. France Erythropoietin (EPO) Drugs Market
            1. France Market Size and Forecast, 2021-2029 (USD Million)
              1. Market Size and Forecast by Drug Class, 2021-2029 (USD Million)
              2. Market Size and Forecast by Product, 2021-2029 (USD Million)
              3. Market Size and Forecast by Application, 2021-2029 (USD Million)
            2. Spain Erythropoietin (EPO) Drugs Market
              1. Spain Market Size and Forecast, 2021-2029 (USD Million)
                1. Market Size and Forecast by Drug Class, 2021-2029 (USD Million)
                2. Market Size and Forecast by Product, 2021-2029 (USD Million)
                3. Market Size and Forecast by Application, 2021-2029 (USD Million)
              2. Italy Erythropoietin (EPO) Drugs Market
                1. Italy Market Size and Forecast, 2021-2029 (USD Million)
                  1. Market Size and Forecast by Drug Class, 2021-2029 (USD Million)
                  2. Market Size and Forecast by Product, 2021-2029 (USD Million)
                  3. Market Size and Forecast by Application, 2021-2029 (USD Million)
                2. Rest of Europe Erythropoietin (EPO) Drugs Market
                  1. Rest of Europe Market Size and Forecast, 2021-2029 (USD Million)
                    1. Market Size and Forecast by Drug Class, 2021-2029 (USD Million)
                    2. Market Size and Forecast by Product, 2021-2029 (USD Million)
                    3. Market Size and Forecast by Application, 2021-2029 (USD Million)
  1. Asia Pacific Erythropoietin (EPO) Drugs Market
    1. Asia Pacific Erythropoietin (EPO) Drugs Market
      1. Asia Pacific Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Drug Class, 2021-2029 (USD Million)
        2. Market Size and Forecast by Product, 2021-2029 (USD Million)
        3. Market Size and Forecast by Application, 2021-2029 (USD Million)
      2. Japan Erythropoietin (EPO) Drugs Market
        1. Japan Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Drug Class, 2021-2029 (USD Million)
          2. Market Size and Forecast by Product, 2021-2029 (USD Million)
          3. Market Size and Forecast by Application, 2021-2029 (USD Million)
        2. China Erythropoietin (EPO) Drugs Market
          1. China Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Drug Class, 2021-2029 (USD Million)
            2. Market Size and Forecast by Product, 2021-2029 (USD Million)
            3. Market Size and Forecast by Application, 2021-2029 (USD Million)
          2. India Erythropoietin (EPO) Drugs Market
            1. India Market Size and Forecast, 2021-2029 (USD Million)
              1. Market Size and Forecast by Drug Class, 2021-2029 (USD Million)
              2. Market Size and Forecast by Product, 2021-2029 (USD Million)
              3. Market Size and Forecast by Application, 2021-2029 (USD Million)
            2. South Korea Erythropoietin (EPO) Drugs Market
              1. South Korea Market Size and Forecast, 2021-2029 (USD Million)
                1. Market Size and Forecast by Drug Class, 2021-2029 (USD Million)
                2. Market Size and Forecast by Product, 2021-2029 (USD Million)
                3. Market Size and Forecast by Application, 2021-2029 (USD Million)
              2. Australia Erythropoietin (EPO) Drugs Market
                1. Australia Market Size and Forecast, 2021-2029 (USD Million)
                  1. Market Size and Forecast by Drug Class, 2021-2029 (USD Million)
                  2. Market Size and Forecast by Product, 2021-2029 (USD Million)
                  3. Market Size and Forecast by Application, 2021-2029 (USD Million)
                2. Rest of Asia Pacific Erythropoietin (EPO) Drugs Market
                  1. Rest of Asia Pacific Market Size and Forecast, 2021-2029 (USD Million)
                    1. Market Size and Forecast by Drug Class, 2021-2029 (USD Million)
                    2. Market Size and Forecast by Product, 2021-2029 (USD Million)
                    3. Market Size and Forecast by Application, 2021-2029 (USD Million)
  1. Latin America Erythropoietin (EPO) Drugs Market
    1. Latin America Erythropoietin (EPO) Drugs Market
      1. Latin America Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Drug Class, 2021-2029 (USD Million)
        2. Market Size and Forecast by Product, 2021-2029 (USD Million)
        3. Market Size and Forecast by Application, 2021-2029 (USD Million)
      2. Brazil Erythropoietin (EPO) Drugs Market
        1. Brazil Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Drug Class, 2021-2029 (USD Million)
          2. Market Size and Forecast by Product, 2021-2029 (USD Million)
          3. Market Size and Forecast by Application, 2021-2029 (USD Million)
        2. Mexico Erythropoietin (EPO) Drugs Market
          1. Mexico Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Drug Class, 2021-2029 (USD Million)
            2. Market Size and Forecast by Product, 2021-2029 (USD Million)
            3. Market Size and Forecast by Application, 2021-2029 (USD Million)
          2. Argentina Erythropoietin (EPO) Drugs Market
            1. Argentina Market Size and Forecast, 2021-2029 (USD Million)
              1. Market Size and Forecast by Drug Class, 2021-2029 (USD Million)
              2. Market Size and Forecast by Product, 2021-2029 (USD Million)
              3. Market Size and Forecast by Application, 2021-2029 (USD Million)
            2. Rest of Latin America Erythropoietin (EPO) Drugs Market
              1. Rest of Latin America Market Size and Forecast, 2021-2029 (USD Million)
                1. Market Size and Forecast by Drug Class, 2021-2029 (USD Million)
                2. Market Size and Forecast by Product, 2021-2029 (USD Million)
                3. Market Size and Forecast by Application, 2021-2029 (USD Million)
  1. MEA Erythropoietin (EPO) Drugs Market
    1. MEA Erythropoietin (EPO) Drugs Market
      1. MEA Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Drug Class, 2021-2029 (USD Million)
        2. Market Size and Forecast by Product, 2021-2029 (USD Million)
        3. Market Size and Forecast by Application, 2021-2029 (USD Million)
      2. GCC Erythropoietin (EPO) Drugs Market
        1. GCC Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Drug Class, 2021-2029 (USD Million)
          2. Market Size and Forecast by Product, 2021-2029 (USD Million)
          3. Market Size and Forecast by Application, 2021-2029 (USD Million)
        2. South Africa Erythropoietin (EPO) Drugs Market
          1. South Africa Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Drug Class, 2021-2029 (USD Million)
            2. Market Size and Forecast by Product, 2021-2029 (USD Million)
            3. Market Size and Forecast by Application, 2021-2029 (USD Million)
          2. Rest of MEA Erythropoietin (EPO) Drugs Market
            1. Rest of MEA Market Size and Forecast, 2021-2029 (USD Million)
              1. Market Size and Forecast by Drug Class, 2021-2029 (USD Million)
              2. Market Size and Forecast by Product, 2021-2029 (USD Million)
              3. Market Size and Forecast by Application, 2021-2029 (USD Million)
  1. Competitor Analysis
    1. Market Share Analysis, 2021 & 2029
    2. Competitive Mapping
    3. Key Players Market Place Analysis
    4. Major Recent Developments
  2. Company Profiles
    1. Reddy’s Laboratories (India)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    2. Sun Pharmaceutical Industries Limited (India)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    3. Shandong Kexing Bioproducts Co.,Ltd. (China)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    4. Biocon Limited (India)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    5. LG Corporation (South Korea)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    6. Hoffmann-La Roche AG (Switzerland)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    7. Amgen Inc. (U.S.)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    8. Teva Pharmaceutical Industries Ltd. (Israel)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    9. Celltrion (South Korea)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    10. Johnson & Johnson (U.S.)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    11. Company 11
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Drug Class Benchmarking
      5. Recent Developments
    12. Company 12
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Drug Class Benchmarking
      5. Recent Developments
    13. Company 13
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Drug Class Benchmarking
      5. Recent Developments
    14. Company 14
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Drug Class Benchmarking
      5. Recent Developments
    15. Company 15
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Drug Class Benchmarking
      5. Recent Developments
    16. Others Prominent Players

Conclusion & Recommendations

Select License Type

Buy Now

7 Reasons to Choose EHMR Reports

  • Customer’s Satisfaction

    First and foremost client’s satisfaction, which is very important for Erevna Healthcare and we are committed towards it

  • Client Report

    Customised reports

    Expert in healthcare domain and in depth insights on the report. Erevna Healthcare also customise reports as per the client’s requirement

  • Analyst Support

    Experienced team of analysts with strong background in Pharma, Life Sciences and Biotechnology

  • Assured Quality

    Each report passes through three tiers of quality check

  • Stick to the timeline

    Stick to the timeline

    Erevna Healthcare analysts stick to the timeline

  • Quick delivery

    Quick delivery of reports as per client’s request in three different forms i.e. pdf, ppt and word

  • 24x7 Supprt

    24*7 Support

    24*7 Support post delivery/dispatch of all the reports

Trending Reports